Biofrontera Bioscience GmbH
Clinical Trials
23
Trial Phases
3 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
- Conditions
- Actinic Keratoses
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Biofrontera Bioscience GmbH
- Target Recruit Count
- 172
- Registration Number
- NCT05662202
- Locations
- 🇺🇸
Medical Dermatology Specialists, Phoenix, Arizona, United States
🇺🇸Alliance Dermatology & Mohs Center, Phoenix, Arizona, United States
🇺🇸Dermatology Practice, Greenwood Village, Colorado, United States
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
- Conditions
- Acne Vulgaris
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Biofrontera Bioscience GmbH
- Target Recruit Count
- 126
- Registration Number
- NCT05080764
- Locations
- 🇺🇸
First OC Dermatology, Fountain Valley, California, United States
🇺🇸Cosmetic Laser Dermatology, San Diego, California, United States
🇺🇸Dermatology Associates PA of the Palm Beaches, Delray Beach, Florida, United States
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
- Conditions
- Keratosis, ActinicActinic KeratosisKeratosis
- First Posted Date
- 2021-09-29
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Biofrontera Bioscience GmbH
- Target Recruit Count
- 112
- Registration Number
- NCT05060237
- Locations
- 🇺🇸
Medical Dermatology Specialists, Phoenix, Arizona, United States
🇺🇸Alliance Dermatology & Mohs Center, Phoenix, Arizona, United States
🇺🇸Dermatology Practice, Greenwood Village, Colorado, United States
Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)
- Conditions
- Actinic Keratoses
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2021-11-11
- Lead Sponsor
- Biofrontera Bioscience GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT04319159
- Locations
- 🇺🇸
DermResearch Inc., Austin, Texas, United States
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
- Conditions
- Superficial Basal Cell Carcinoma
- First Posted Date
- 2018-06-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Biofrontera Bioscience GmbH
- Target Recruit Count
- 187
- Registration Number
- NCT03573401
- Locations
- 🇺🇸
Medical Dermatology Specialists, Phoenix, Arizona, United States
🇺🇸Alliance Dermatology & Mohs Center, Phoenix, Arizona, United States
🇺🇸First OC Dermatology, Fountain Valley, California, United States
- Prev
- 1
- 2
- Next